Abstract |
The in vivo antiplasmodial activity of voacamine was assessed in a 4-day test. It was shown to exhibit in vivo activity with 25.4% and 43.4% inhibition of parasitaemia with 2.5 and 10 mg/kg, respectively. In synchronized cultures, it was found to act on trophozoite and schizont stages of Plasmodium falciparum. Using the FMC29 strain of Plasmodium falciparum as parasite and the isobologram curve as a method to assess interaction in drug combination, it was shown to lack any chloroquine-enhancing activity and its in vitro antiplasmodial effect was not potentiated by the chemosensitizer malagashanine.
|
Authors | D Ramanitrahasimbola, P Rasoanaivo, S Ratsimamanga-Urverg, E Federici, G Palazzino, C Galeffi, M Nicoletti |
Journal | Phytotherapy research : PTR
(Phytother Res)
Vol. 15
Issue 1
Pg. 30-3
(Feb 2001)
ISSN: 0951-418X [Print] England |
PMID | 11180519
(Publication Type: Journal Article)
|
Copyright | Copyright -Copyright 2001 John Wiley & Sons, Ltd. |
Chemical References |
- Alkaloids
- Antimalarials
- malagashanine
- voacamine
- Ibogaine
- Chloroquine
|
Topics |
- Alkaloids
(pharmacology)
- Animals
- Antimalarials
(pharmacology)
- Chloroquine
(pharmacology)
- Drug Synergism
- Ibogaine
(analogs & derivatives, pharmacology)
- Mice
- Microbial Sensitivity Tests
- Plasmodium falciparum
(drug effects)
- Plasmodium yoelii
(drug effects)
|